Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Int J Mol Sci. 2021 Mar 24;22(7):3306. doi: 10.3390/ijms22073306.
Both type 1 and type 2 diabetes are characterized by a progressive loss of beta cell mass that contributes to impaired glucose homeostasis. Although an optimal treatment option would be to simply replace the lost cells, it is now well established that unlike many other organs, the adult pancreas has limited regenerative potential. For this reason, significant research efforts are focusing on methods to induce beta cell proliferation (replication of existing beta cells), promote beta cell formation from alternative endogenous cell sources (neogenesis), and/or generate beta cells from pluripotent stem cells. In this article, we will review (i) endogenous mechanisms of beta cell regeneration during steady state, stress and disease; (ii) efforts to stimulate endogenous regeneration and transdifferentiation; and (iii) exogenous methods of beta cell generation and transplantation.
1 型和 2 型糖尿病的特征均为β细胞数量进行性减少,导致葡萄糖稳态受损。虽然理想的治疗方法是简单地替代丢失的细胞,但现在已经明确,与许多其他器官不同,成年胰腺的再生潜能有限。出于这个原因,大量的研究工作集中在诱导β细胞增殖(现有β细胞的复制)、促进替代内源性细胞来源的β细胞形成(新生),以及/或从多能干细胞生成β细胞的方法上。在本文中,我们将回顾(i)在稳态、应激和疾病期间β细胞再生的内源性机制;(ii)刺激内源性再生和转分化的努力;以及(iii)β细胞生成和移植的外源性方法。